Você está deixando o Portal Médico GSK

Você está prestes a deixar o site da GSK. Ao clicar neste link, você será direcionado a um site que não pertence ou é controlado pela GSK. Portanto, a GSK não é responsável por demais conteúdos presentes neste site.

Continuar

Voltar

Coqueluche: prevenção da doença em prematuros e imunização durante a gestação

Dra. Pilar Rubio e Dr. Attila Mihaly discutem sobre a vacinação contra coqueluche em crianças prematuras, a importância da vacinação durante a gestação e os impactos no neonato. Além disso, abordam a importância da troca de informações científicas relacionadas à coqueluche entre os profissionais da saúde envolvidos no cuidado da gestante e recém-nascido.

   

  • 1. WORLD HEALTH ORGANIZATION. Vaccine-preventable diseases: monitoring system. 2018 global summary. Disponível em: <http://apps.who.int/immunization_monitoring/globalsummary/schedules?sc%5Br%5D%5B%5D=AFRO&sc%5Br%5D%5B%5D=AMRO&sc%5Br%5D%5B%5D=EMRO&sc%5Br%5D%5B%5D=EURO&sc%5Br%5D%5B%5D=SEARO&sc%5Br%5D%5B%5D=WPRO&sc%5Bd%5D=&sc%5Bv%5D%5B%5D=TDAP&sc%5BOK%5D=O>. Acesso em: 07 jun. 2018.

    2. EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL. Vaccine schedules in all countries of the European Union. Disponível em: <https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByDisease? SelectedDiseaseId=3&SelectedCountryIdByDisease=-1>. Acesso em: 09 mar. 2018.

    3. CENTERS FOR DISEASE CONTROL AND PREVENTION. Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women — ACIP, 2012. MMWR 2013;62: 131-135.

    4. STATE OF ISRAEL MINISTRY OF HEALTH. Whooping Cough Vaccination in Pregnant Women. Disponível em: <http://www.health.gov. il/English/Topics/Pregnancy/during/Pages/Vaccination-Whooping_cough.aspx> Acesso em: 09 mar. 2018.

    5. SPAIN. Ministerio de Sanidad, Servicios Sociales e Igualdad. Adenda Actualización en Revisión del programa de vacunación frente a tos ferina en España. Disponível em: <http://www.msssi.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/docs/Adenda_TosFerinaEmbarazo.pdf>. Acesso em: 09 mar. 2018.

    6. VASHISHTHA, V.M. Indian Acad-emy of Pediatrics (IAP) Recommended Immunization Schedule for Children Aged 0 through 18 years – India, 2014 and Updates on Immunization. Indian Academy of Pediatrics, 51:785-800, 2014.

    7. IRELAND. Feidhmeannacht na Seirbhíse Sláinte Health Service Executive. Whooping Cough Vaccine for Pregnant Women. Disponível em: <http://www.hse.ie/eng/health/immunisation/hcpinfo/OtherVaccines/pertussis/pertussisengleaf.pdf>. Acesso em: 09 mar. 2018.

    8. PUBLIC HEALTH ENGLAND. Vaccination against pertussis (Whooping cough) for pregnant women – 2016. Disponível em: < https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/529956/FV_JUNE_2016_PHE_pertussis_in_pregnancy_information_for_HP_.pdf>. Acesso em: 09 mar. 2018.

    9. AUSTRALIA. Department of Health. The Australian Immunisation Handbook 10th Ed. 2015. Disponível em: <http://www.immunise.health.gov. au/internet/immunise/publishing.nsf/Content/7B28E87511E08905CA257D4D001DB1F8/$File/Aus-Imm-Handbook.pdf>. Acesso em: 09 mar. 2018.

    10. NEW ZEALAND. Ministry of Health. Immunisation of special groups. In: ____. Immunisation Handbook 2017: (2nd edition, march 2018). 2. ed. Wellington: Ministry of Health, 2018. p. 113-6. Disponível em: < https://www.health.govt.nz/system/files/documents/publications/immunisation-handbook-2017-2nd-ed-mar18.pdf>. Acesso em: 09 mar. 2018.

    11. CANADA. Public Health Agency. Canadian Immunization Guide: Part 3 – Vaccination of Specific Populations. Disponível em: < https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-3-vaccination-specific-populations/page-4-immunization-pregnancy-breastfeeding.html>. Acesso em: 09 mar. 2018.

    12. POTIN, M. et al. Strategies to protect the newborn and infants under 6 months of age against pertussis. Rev Chilena Infectol 2016; 33 (5): 543-546 15.

    13. SÁFADI, M.A.P. Pertussis in young infants: a severe vaccine-preventable disease. Autopsy Case Rep. 2015; 5(2):1-4. 16.

    14. EL SALVADOR. Ministerio de Salud. Esquema Nacional de Vacunación El Salvador 2017. Disponível em: <http://www.salud.gob.sv/esquema-nacional-de-vacunacion-el-salvador-2017/>. Acesso em: 09 mar. 2018.

    15. NETHERLANDS. Health council. Executive Summary - Vaccination against pertussis: aims and strategy. Disponível em: <http://www.gezondheidsraad.nl/sites/default/files/summary_201529_vaccinatie_tegen_kinkhoest_doel_en_strategie_0.pdf>. Acesso em: 09 mar. 2018.

    16. SLOVENIA. Instructions for implementing immunization program 2017. Disponível em: <http://www.nijz.si/sites/www.nijz.si/files/uploaded/navodila_za_izvajanje_ip_2017.pdf>. Acesso em: 09 mar. 2018.

    17. SWITZERLAND. Anpassung der Impfempfehlung gegen Pertussis. Disponível em: <http://www.susannespoerri.ch/pdf/09_BAG_D_Impfempfehlung_Pertussis.pdf >. Acesso em: 09 mar. 2018.

    18. TAIWAN. Ministry of Health and Welfare. Infectious Disease Prevention and Control Group 103. Disponível em: <http://61.57.41.133/downloadfile.aspx?fid=0AF604D3E0C0027A>. Acesso em: 09 mar. 2018.

    19. PHILIPPINES . Philippine Foundation for Vaccination. Adult Immunization Schedule (2015). Disponível em: <http://www.thefilipinodoctor.com/cpm_pdf/CPM17th%20Adult%20Immunization%20Schedule.pdf>. Acesso em: 09 mar. 2018.

    20. QATAR MINISTRY OF PUBLIC HEALTH. Tdap vaccine recommendations for pregnant women. Publicado em fev. 2017.

    21. SINGAPORE. Ministry of Health. National Adult Immunisation Schedule – Recommendations for adult vaccinations. MoH Circular 23/2017.

    22. CHOI, W.S. et al. Revised adult immunization guideline recommended by the korean society of infectious diseases 2014. Journal of Infection and Chemotherapy, 2015;47: 68-79.

    23. SAARI, TN. et al. Immunization of Preterm and Low Birth Weight Infants. Pediatrics, 112(1 Pt 1):193–198, 2003.

    24. COMMITTEE ON INFECTIOUS DISEASES AMERICAN ACADEMY OF PEDIATRICS. Red Book 2009 Report of the committee on infectious diseases, 2009. Disponível em: <https://redbook.solutions.aap.org/DocumentLibrary/RB2009.pdf>. Acesso em: 06 jun. 2018.

    25. OMEÑACA, F. et al. Immunization of preterm infants with GSK’s hexavalent combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine: A review of safety and immunogenicity. Vaccine, 36(7): 986-996, 2018.

    26. WORLD HEALTH ORGANIZATION. Summary of WHO Position Papers - Recommendations for Routine Immunization. Disponível em: <http://www.who.int/immunization/policy/Immunization_routine_table1.pdf?ua=1>. Acesso em: 06 jun. 2018.

    27. KROGER, AT. et al. General Best Practice Guidelines for Immunization: Best Practices Guidance of the Advisory Committee on Immunization Practices (ACIP). Disponível em: <www.cdc.gov/vaccines/hcp/acip-recs/general-recs/downloads/general-recs.pdf>. Acesso em: 06 jun. 2018.

    28. ROBERT KOCH INSTITUT. Statement of the German standing committee on vaccination at the RKI Recommendations of the Standing Committee on Vaccination (STIKO) at the Robert Koch Institute – 2017/2018. Epidemiologisches Bulletin, 34: 333-76, 2017. Disponível em: <https://www.rki.de/EN/Content/infections/Vaccination/recommandations/34_2017_engl.pdf?__blob=publicationFile>. Acesso em: 06 jun. 2018.

    29. AMIRTHALINGAM, G. et al. Effectiveness of maternal pertussis vaccination in England: an observational study.  Lancet, 384:1521–1528, 2014.

    30. INFANRIX HEXA [vacina adsorvida difteria, tétano, pertussis (acelular), hepatite B (recombinante), poliomielite 1, 2 e 3 (inativada) e Haemophilus influenzae b (conjugada)]. Bula do produto.

    31. BAXTER, D. Impaired functioning of immune defenses to infection in premature and term infants and their implications for vaccination. Hum Vaccin, 6:494–505, 2010.

    32. MCCROSSAN P. et al. Retrospective review of administration of childhood primary vaccination schedule in an Irish tertiary neonatal intensive care unit. Public Health 2015;129: 896–898, 2015.

    33. GAGNEUR, A. et al. Immunization of preterm infants. Hum Vaccin Immunother, 11: 2556–2563, 2015.

    34. RIISE, OR. et al. Risk of Pertussis in Relation to Degree of Prematurity in Children Less Than 2 Years of Age. Pediatr Infect Dis, 36: e151–e156, 2017.

    35. SHINEFIELD, H. et al. Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants. Pediatr Infect Dis J, 21:182–186, 2002.

    36. NEWMAN, RD. et al. Perinatal risk factors for infant hospitalization with viral gastroenteritis. Pediatrics, 103(1): E3, 1999.

    37. GARCIA, M et al. Clinical predictors of disease severity during the 2009-2010 A(HIN1) influenza virus pandemic in a paediatric population. Epidemiol Infect, 143: 2939–2949, 2015.

    38. PETOUSIS-HARRIS, H. et al. Safety of Tdap vaccine in pregnant women: an observational study. BMJ, 6: 1-11, 2016. 

    39. OMEÑACA, F. et al. Antibody Persistence and Booster Vaccination During the Second and Fifth Years of Life in a Cohort of Children Who Were Born Prematurely. Pediatr. Infect. Dis. 26: 824-829, 2007.

As marcas registradas pertencem ou são licenciadas ao grupo de empresas GSK. Errata: BR/VAC/0083/18ab